Sei Investments Co. Has $10.41 Million Holdings in Colgate-Palmolive (NYSE:CL)

Sei Investments Co. lifted its stake in Colgate-Palmolive (NYSE:CL) by 29.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 142,835 shares of the company’s stock after buying an additional 32,777 shares during the quarter. Sei Investments Co.’s holdings in Colgate-Palmolive were worth $10,406,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the company. FDx Advisors Inc. increased its holdings in shares of Colgate-Palmolive by 104.3% in the third quarter. FDx Advisors Inc. now owns 7,344 shares of the company’s stock valued at $535,000 after purchasing an additional 3,749 shares during the last quarter. Global X MANAGEMENT CO LLC increased its holdings in shares of Colgate-Palmolive by 8.2% in the third quarter. Global X MANAGEMENT CO LLC now owns 9,836 shares of the company’s stock valued at $717,000 after purchasing an additional 743 shares during the last quarter. YCG LLC increased its holdings in shares of Colgate-Palmolive by 1.0% in the third quarter. YCG LLC now owns 477,865 shares of the company’s stock valued at $34,825,000 after purchasing an additional 4,505 shares during the last quarter. Bessemer Group Inc. increased its holdings in shares of Colgate-Palmolive by 0.8% in the third quarter. Bessemer Group Inc. now owns 2,384,572 shares of the company’s stock valued at $173,716,000 after purchasing an additional 19,311 shares during the last quarter. Finally, Roffman Miller Associates Inc. PA increased its stake in Colgate-Palmolive by 4.2% during the third quarter. Roffman Miller Associates Inc. PA now owns 200,786 shares of the company’s stock worth $14,627,000 after acquiring an additional 8,170 shares during the last quarter. Hedge funds and other institutional investors own 72.83% of the company’s stock.

Shares of Colgate-Palmolive (NYSE:CL) opened at $74.62 on Friday. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27. The firm has a market capitalization of $65,520.00, a P/E ratio of 28.81, a price-to-earnings-growth ratio of 3.15 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The business had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.73 EPS. equities research analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.

In other Colgate-Palmolive news, Director Stephen I. Sadove sold 20,780 shares of the business’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares in the company, valued at approximately $2,557,619.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction on Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at $3,313,501.76. The disclosure for this sale can be found here. Insiders sold a total of 181,950 shares of company stock valued at $13,237,385 over the last quarter. 1.02% of the stock is currently owned by insiders.

Several equities research analysts have issued reports on the company. SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their target price for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Societe Generale lowered Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Citigroup decreased their target price on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Finally, Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have given a buy rating to the company’s stock. Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $76.51.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/01/14/colgate-palmolive-cl-shares-bought-by-sei-investments-co.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply